Unknown NA INTERVENTIONAL 1-arm NCT04438564

Immunoassay and Regulation of Traditional Chinese Medicine on Cancer Patients

Sponsor: China Medical University Hospital

Conditions Breast Cancer Cancer of Endometrium Cancer of Ovary Colorectal Cancer

Interventions Cases for patients diagnosed with breast cancer, colonrectal cancer, ovarian cancer and endometrial cancer

Updated 7 times since 2020 Last updated: Feb 6, 2023 Started: May 18, 2020 Primary completion: Jul 31, 2023 Completion: Jul 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Breast Cancer and Cancer of Endometrium, this trial is ongoing. The trial is conducted by China Medical University Hospital and has accumulated 7 data snapshots since 2020. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Mar 2025 — Present [monthly]

Unknown NA

Status: Recruiting → Unknown
Sep 2024 — Mar 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Mar 2023 — Jul 2024 [monthly]

Recruiting NA
Sep 2021 — Mar 2023 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Jan 2021 — Sep 2021 [monthly]

Recruiting NA
Jul 2020 — Jan 2021 [monthly]

Recruiting NA

First recorded

May 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

China Medical University Hospital

Data source: China Medical University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taichung, Taiwan